Metraipolis › archive › dc_211abae36d4d

The latest research progress of ligustilide in the prevention and treatment of central nervous system disorders — Europe PMC PMID:42440665

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42440665
DOI
10.3389/fphar.2026.1843537
License (as archived)
solo-consultazione
Archived
2026-10-19T06:37:24.915Z
SHA-256 of the archived text
4c068b4f032fa1c9ff5dc9d693407b03de13a8748f3b8148897e78fdf40fc369
Stable URL of this page
https://metraipolis.com/documento/dc_211abae36d4d

How to cite

The latest research progress of ligustilide in the prevention and treatment of central nervous system disorders — Europe PMC PMID:42440665 — Europe PMC (en), https://europepmc.org/article/MED/42440665 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_211abae36d4d (Metraipolis archive dc_211abae36d4d, sha256 4c068b4f032fa1c9ff5dc9d693407b03de13a8748f3b8148897e78fdf40fc369)
BibTeX
@misc{dc211abae36d4d,
  title = {The latest research progress of ligustilide in the prevention and treatment of central nervous system disorders — Europe PMC PMID:42440665},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42440665},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_211abae36d4d; sha256 4c068b4f032fa1c9ff5dc9d693407b03de13a8748f3b8148897e78fdf40fc369},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42440665. Agents can read the archived copy with the MCP tool read_document.